On the pathogenesis of destructive pneumonia during COVID-19: a clinical case

Community-acquired pneumonia is a potentially serious infection in children with high morbidity rate, risk of severe course and unfavorable outcomes. Specialists have noted the increased incidence of the destructive forms in the recent years.

Aim. To present a clinical case of destructive pneumonia in a 1 year 2 month old child, hospitalized in the State Budgetary Healthcare Institution “Children’s City Clinical Hospital of St. Vladimir Moscow Healthcare Department”, and analyze it in terms of current understanding on the disease pathogenesis.

Conclusion. During COVID-19 (COronaVIrus Disease 2019) pandemic, pulmonologists and pediatric surgeons encountered an unconventional course of destructive pneumonia. A large number of studies of pathophysiological processes in acute viral interstitial pneumonias have recently allowed to expand our understanding of the role of coagulation system. At the same time, new questions arose concerning the clinical course and development of the pathological infectious process.

1. Yun K.W., Wallihan R., Juergensen A., Ramilo O. Community-acquired pneumonia in children: myths and facts. Am. J. Perinatol. 2019; 36 (Suppl. 2): S54–57. DOI: 10.1055/s-0039-1691801.

2. Vecherkin V.A., Toma D.A., Ptitsyn V.A. [Destructive pneumonias in children]. Rossiyskiy vestnik detskoy khirurgii, anesteziologii i reanimatologii. 2019; 9 (4): 108–115. DOI: 10.30946/2219-4061-2019-9-3-108-115 (in Russian).

3. Beloborodova N.V., Tarakanov V.A., Barova N.K. [Analysis of destructive pneumonia causes in children, and opportunities of antimicrobial therapy optimization]. Pediatriya. 2016; 95 (2): 66–71. Available at: https://pediatriajournal.ru/files/upload/mags/351/2016_2_4570.pdf (in Russian).

4. Chuchalin A.G., ed. [Respiratory Medicine: a guide]. Moscow: GEOTAR-Media, 2017; Vol. 3 (in Russian).

5. Chapman S.J., Lee Y.C.G., Davies R.J.O. Empyema lung abscess and necrotizing pneumonia. In: Mandell L., Woodhead M., Ewig S., Torres A. Respiratory Infections. 1st edn. London: CRC Press; 2006: 385–400. DOI: 10.1201/b13421.

6. Gross I., Gordon O., Cohen-Cymberknoh M. et al. Giant lung cysts following necrotizing pneumonia: Resolution with conservative treatment. Pediatr. Pulmonol. 2019; 54 (6): 901–906. DOI: 10.1002/ppul.24321.

7. Ness-Cochinwala M., Kobaitri K., Totapally B.R. Characteristics and outcomes of children with necrotizing pneumonia. Pediatr. Crit. Care Med. 2021; 22 (12): e640–643. DOI: 10.1097/PCC.0000000000002793.

8. Krenke K., Sanocki M., Urbankowska E. et al. Necrotizing pneumonia and its complications in children. Adv. Exp. Med. Biol. 2015; 857: 9–17. DOI: 10.1007/5584_2014_99.

9. Díaz-Conradi A., García-García J.J., González Peris S. et al. [Characteristics of patients with invasive pneumococcal disease requiring admission to intensive care units]. An. Pediatr. (Engl. Ed.). 2021; 94 (1): 19–27. DOI: 10.1016/j.anpedi.2020.03.013 (in Spanish).

10. Ko W.T.D. Review on paediatric necrotising pneumonia and its pulmonary co-morbidities. J. Pediatr. Respir. Crit. Care. 2014; 10 (4): 20–31. Available at: http://www.hkspra.org/product_image_pub/270_983722.pdf

11. Lai J.Y., Yang W., Ming Y.C. Surgical management of complicated necrotizing pneumonia in children. Pediatr. Neonatol. 2017; 58 (4): 321–327. DOI: 10.1016/j.pedneo.2016.06.002.

12. Xu J., Zhang Y., Li Y. et al. Dynamic changes in coagulation function in patients with pneumonia under admission and non-admission treatment. Front. Med. (Lausanne). 2021; 8: 626384. DOI: 10.3389/fmed.2021.626384.

13. Antoniak S. The coagulation system in host defense. Res. Pract. Thromb. Haemost. 2018; 2 (3): 549–557. DOI: 10.1002/rth2.12109.

14. Yang H., Ko Y.H., Yang J.Y.et al. Interleukin-1 promotes coagulation, which is necessary for protective immunity in the lung against Streptococcus pneumoniae infection. J. Infect. Dis. 2013; 207 (1): 50–60. DOI: 10.1093/infdis/jis651.

15. Crosby H.A., Kwiecinski J., Horswill A.R. Staphylococcus aureus aggregation and coagulation mechanisms, and their function in host-pathogen interactions. Adv. Appl. Microbiol. 2016; 96: 1–41. DOI: 10.1016/bs.aambs.2016.07.018.

16. Cheng A.G., DeDent A.C., Schneewind O., Missiakas D. A play in four acts: Staphylococcus aureus abscess formation. Trends Microbiol. 2011; 19 (5): 225–232. DOI: 10.1016/j.tim.2011.01.007.

17. Tsai Y.F., Ku Y.H. Necrotizing pneumonia: a rare complication of pneumonia requiring special consideration. Curr. Opin. Pulmon. Med. 2012;18 (3): 246–252. DOI: 10.1097/MCP.0b013e3283521022.

18. Savenkova M.S., Vrublevskiy S.G., Koltunov I.E. et al. [Destructive pneumonia in children: complex issues of diagnosis and choice of individual etiopathogenetic therapy]. Farmateka. 2015; (14): 34–40. Available at: https://pharmateca.ru/ru/archive/article/31925 (in Russian).

19. Chatha N., Fortin D., Bosma K.J. Management of necrotizing pneumonia and pulmonary gangrene: a case series and review of the literature. Can. Respir. J. 2014; 21 (4): 239–245. DOI: 10.1155/2014/864159.

20. Tatochenko V.K. [Community-acquired pneumonia in children – problems and solutions]. Rossiyskiy vestnik perinatologii i pediatrii. 2021; 66 (1): 9–21. DOI: 10.21508/1027-4065-2021-66-1-9-21 (in Russian).

21. Khaspekov D.V., Ol’khova E.B., Topilin O.G. et al. [Modern methods of diagnostics and treatment of destructive pneumonia in children]. Rossiyskiy vestnik detskoy khirurgii, anesteziologii i reanimatologii. 2015; 5 (2): 7–12. Available: https://rps-journal.ru/jour/article/view/152 (in Russian).

22. Masters I.B., Isles A.F., Grimwood K. Necrotizing pneumonia: an emerging problem in children? Pneumonia (Nathan). 2017; 9: 11. DOI: 10.1186/s41479-017-0035-0.

23. Ministry of Health of the Russian Federation. [Acute purulent destructive pneumonia in children: Clinical guidelines]. 2018. Available at: https://diseases.medelement.com/disease/острые-гнойные-деструктивные-пневмонии-у-детей-кр-рф-2018/16734 (in Russian).

24. Gurumurthy B., Das S.K., Hiremath R. et al. Spectrum of atypical pulmonary manifestations of COVID-19 on computed tomography. Egypt. J. Radiol. Nucl. Med. 2021; 52: 72. DOI: 10.1186/s43055-02100448-7.

25. Chen Y., Chen W., Zhou J. et al. Large pulmonary cavity in COVID-19 cured patient case report. Ann. Palliat. Med. 2021; 10 (5): 5786–5791. DOI: 10.21037/apm-20-452.

26. Murayama D., Kojima D., Hino A. et al. A case of bulla formation after treatment for COVID-19 pneumonia. Radiol. Case Rep. 2021; 16 (5): 1162–1164. DOI: 10.1016/j.radcr.2021.03.003.

27. Kruse J.M., Zickler D., Lüdemann W.M. et al. Evidence for a thromboembolic pathogenesis of lung cavitations in severely ill COVID-19 patients. Sci. Rep. 2021; 11 (1): 16039. DOI: 10.1038/s41598-02195694-0.

28. Koroscil M.T., Hauser T.R. Acute pulmonary embolism leading to cavitation and large pulmonary abscess: a rare complication of pulmonary infarction. Respir. Med. Case Rep. 2016; 20: 72–74. DOI: 10.1016/j.rmcr.2016.12.001.

29. Homaira N., Jaffe A. Pleural effusion, necrotizing pneumonia and long-term morbidity of respiratory infection in childhood. In: Janes S.M., ed. Encyclopedia of respiratory medicine. 2rd edn. London: Academic Press; 2022: 132–145. DOI: 10.1016/B978-0-08-102723-3.00025-1

30. Yazer J., Giacomantonio M., MacDonald N., Lopushinsky S. Severe necrotizing pneumonia in a child with pandemic (H1N1) influenza. CMAJ. 2011; 183 (2): 215–219. DOI: 10.1503/cmaj.100285.

31. Guidi R., Osimani P., Azzari C. et al. Severe necrotizing pneumonia complicating influenza A (H1N1): the role of immunologic interaction. Int. J. Immunopathol. Pharmacol. 2011; 24 (4): 1093–1197. DOI: 10.1177/039463201102400429.

32. Brealey J.C., Sly P.D., Young P.R., Chappell K.J. Viral bacterial co-infection of the respiratory tract during early childhood. FEMS Microbiol. Lett. 2015; 362 (10): fnv062. DOI: 10.1093/femsle/fnv062.

33. Liu J., He R., Wu R. et al. Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children’s hospital. BMC Infect. Dis. 2020; 20 (1): 51. DOI: 10.1186/s12879-020-4774-9